EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Statins—From Fungi to Pharmacy

Anna Sadowska iD, Patryk Osiński, Alicja Roztocka, Karolina Kaczmarz-Chojnacka, Ewa Zapora iD, Diana Sawicka iD, Halina Car

International Journal of Molecular Sciences · 29.12.2023 · 25 (1) · 466

DOI: 10.3390/ijms25010466 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.12.2023. Verfasst von Anna Sadowska und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Pharmacology, Medical University of Bialystok, Szpitalna 37, 15-295 Bialystok, Poland. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Pharmacy. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 207 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Białystok, Medical University of Bialystok.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Statins have been used in the treatment of hyperlipidemia, both as monotherapy and in combination therapy. Natural fermentation processes of fungi such as Monascus spp., Penicillium spp., Aspergillus terreus, and Pleurotus ostreatus have given rise to natural statins. Compactin (mevastatin), the original naturally occurring statin, is the primary biotransformation substrate in the manufacturing process of marketed drugs. Statins are classified into natural, semi-synthetic derivatives of natural statins, and synthetic ones. Synthetic statins differ from natural statins in their structural composition, with the only common feature being the HMG-CoA-like moiety responsible for suppressing HMG-CoA reductase. Statins do not differ significantly regarding their pleiotropic and adverse effects, but their characteristics depend on their pharmacokinetic parameters and chemical properties. This paper focuses on describing the processes of obtaining natural statins, detailing the pharmacokinetics of available statins, divided into natural and synthetic, and indicating their pleiotropic effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsPharmacyFungiLovastatin

Stichwörter der Autor:innen

HMG-CoA reductasecholesterolfungistatins

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsmevastatinLovastatin

Autor:innen und Institutionen

  • Department of Experimental Pharmacology, Medical University of Bialystok, Szpitalna 37, 15-295 Bialystok, Poland.
  • Student's Pharmacological Club, Lazarski University, Świeradowska 43, 02-662 Warsaw, Poland.
  • Department of Silviculture and Forest Use, Institute of Forest Sciences, Bialystok University of Technology, Wiejska 45E, 15351 Bialystok, Poland.

ORCID-Profile: Anna Sadowska, Ewa Zapora, Diana Sawicka

Förderung

  • Medical University of Białystok
  • Medical University of Bialystok

Zitieren

APA

Sadowska, A., Osiński, P., Roztocka, A., Kaczmarz-Chojnacka, K., Zapora, E., Sawicka, D., & Car, H. (2023). Statins—From Fungi to Pharmacy. International Journal of Molecular Sciences, 25(1), 466. https://doi.org/10.3390/ijms25010466

Vancouver

Sadowska A, Osiński P, Roztocka A, Kaczmarz-Chojnacka K, Zapora E, Sawicka D, et al. Statins—From Fungi to Pharmacy. International Journal of Molecular Sciences. 2023;25(1):466. doi:10.3390/ijms25010466

BibTeX
@article{Sadowska2023,
  author = {Sadowska, Anna and Osiński, Patryk and Roztocka, Alicja and Kaczmarz-Chojnacka, Karolina and Zapora, Ewa and Sawicka, Diana and Car, Halina},
  title = {Statins—From Fungi to Pharmacy},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {25},
  number = {1},
  pages = {466},
  doi = {10.3390/ijms25010466}
}
Kostenlos starten →